Oarsman Capital’s Omnicell OMCL Stock Holding History

Oarsman Capital’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-316	Closed	-$14.1K	–	645
2024 Q4	$14.1K	Buy	316 +19	+6%	+$853	﹤0.01%	646
2024 Q3	$12.9K	Buy	+297	New	+$11.2K	﹤0.01%	665

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oarsman Capital's OMCL Position: Q1 2025 in Review

Oarsman Capital sold out of Omnicell (OMCL) in Q1 2025, closing a stake of 316 shares — an estimated $14.1K sold.

Oarsman Capital first reported a position in OMCL in Q3 2024 and held it in 2 quarters. The position peaked at $14.1K in Q4 2024. 274 funds tracked by Wall St. Rank hold OMCL as of Q1 2025.

Oarsman Capital reported no remaining Omnicell position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 316 Omnicell shares in Q1 2025, an estimated $14.1K.
Oarsman Capital first reported a position in Omnicell in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Omnicell position peaked at $14.1K in Q4 2024.
274 funds tracked by Wall St. Rank held Omnicell as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.